Here, we demonstrate that knocking down AURKA in a doxycycline-inducible system or inhibiting AURKA by MLN8237 improves cisplatin and radiation activity in multiple lung cancer cell lines and in an in vivo xenograft model. The gene discussed is AURKA; the disease is lung cancer.